William Kang
@Marshall Wace, Llp
Latest period2024 - Q3ReportedManaged Assets$82.101BTotal holdings2318
Assets growth rate9.63%Assets growth rate (2-Q avg)11.84%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Marshall Wace, Llp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 2318 positions.
Assets under management
The assets under management (AUM) of Marshall Wace, Llp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 82.101B in assets, with a quarterly growth rate of 9.63% and a 2-quarter average growth rate of 11.84%. The portfolio is managed by William Kang, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
6291⤦Nio Inc
| 0.03% | $20.725M 23.5M shares@ $0.89 avg price | New Position |
TELTe Connectivity
| 0.03% | $20.402M 135,123 shares@ $151.0 avg price | New Position |
EIXEdison Intl
| 0.03% | $20.343M 233,584 shares@ $87.1 avg price | New Position |
EGPEastgroup Prop
| 0.03% | $19.709M 105,499 shares@ $186.83 avg price | New Position |
CZRCaesars Entertai
| 0.03% | $19.706M 472,107 shares@ $41.75 avg price | New Position |
MCHPMicrochip Tech
| 0.03% | $19.228M 239,479 shares@ $80.3 avg price | New Position |
AKRAcadia Realty
| 0.03% | $18.059M 769,140 shares@ $23.48 avg price | New Position |
NHINatl Health Inv
| 0.03% | $17.726M 210,873 shares@ $84.07 avg price | New Position |
CFGCitizens Financi
| 0.03% | $17.494M 425,950 shares@ $41.07 avg price | New Position |
ALNYAlnylam Pharmace
| 0.03% | $17.455M 63,467 shares@ $275.03 avg price | New Position |